Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-06-18
1981-06-30
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546276, 546310, 546324, A61K 3144, C07D40104
Patent
active
042762979
ABSTRACT:
A series of novel 3-amino-5-(4-pyridyl)-1,2,4-triazole derivatives has been prepared, including their pharmaceutically acceptable acid addition salts. These particular compounds are useful in therapy as anti-ulcer agents. Preferred member compounds include 3-amino-5-[2-(N-monomethylamino)-4-pyridyl]-1,2,4-triazole, 3-amino-5-[2-(N-monoethylamino)-4-pyridyl]-1,2,4-triazole and 3-amino-5-[2-(N,N-dimethylamino)-4-pyridyl]-1,2,4-triazole. Alternate methods of preparation are provided and the principal synthetic routes leading to the preferred compounds are described in some detail.
REFERENCES:
patent: 3647814 (1972-03-01), Greenfield
patent: 3663527 (1972-05-01), Schonenbuch
patent: 3813400 (1974-05-01), Boyle et al.
patent: 3873563 (1975-03-01), Kotone et al.
patent: 3879404 (1975-04-01), Baldwin et al.
patent: 4071518 (1978-01-01), Baldwin et al.
patent: 4102889 (1978-07-01), Baldwin et al.
Chem. Abstracts 48:12092 d.
Chem. Abstracts 58:5703 h.
Annual Reports in Medicinal Chem., vol. 14, pp. 91-102, (1979).
Bieman et al., Monatshefte fur Chemie, vol. 89, Nos. 4-5, p. 603, (1958).
Jones et al., Journ. Medicinal Chem., vol. 8, p. 676, (1965).
Yakugaku Zashi, Journ. Pharm. Soc. Japan, vol. 92, No. 4, p. 471, (1972).
Love Ethel G.
Pfizer Inc.
LandOfFree
Pyridylaminotriazole therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridylaminotriazole therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridylaminotriazole therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2434315